H.G. Meerpohl
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 5
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 3
- Biophysics top 5%
- Oncology top 10%
- Cancer Treatment and Pharmacology 11
- HER2/EGFR in Cancer Research 5
- Immunology top 10%
- Immune cells in cancer 3
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
-
- Chemotherapy-related skin toxicity 4
-
- Intraperitoneal and Appendiceal Malignancies 3
- Co-authors
- Marie‐Luise Lohmann‐MatthesHerbert FischerAndreas du BoisJalid SehouliH EnglerG. W. LöhrWolfram BruggerReinhard Andreesen
- Journals
- Journal of Clinical Oncology (3 papers)European Journal of Immunology (2 papers)European Journal of Cancer (1 paper)
- Partner nations
- GermanySwitzerlandEstonia
In The Last Decade
H.G. Meerpohl
26 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 90
- Reproductive Medicine 360
- Obstetrics and Gynecology 163
- Biophysics 93
- Oncology 408
- Immunology 222
Countries citing papers authored by H.G. Meerpohl
This map shows the geographic impact of H.G. Meerpohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.G. Meerpohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.G. Meerpohl more than expected).
Fields of papers citing papers by H.G. Meerpohl
This network shows the impact of papers produced by H.G. Meerpohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.G. Meerpohl. The network helps show where H.G. Meerpohl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H.G. Meerpohl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 55 | |
| 2 | 2010 | 20 | |
| 3 | 2010 | 7 | |
| 4 | 2010 | 98 | |
| 5 | 2010 | 76 | |
| 6 | 2007 | 20 | |
| 7 | 2006 | 44 | |
| 8 | 2006 | 275 | |
| 9 | Anthracycline and trastuzumab in breast cancer treatment. | 2004 | 6 |
| 10 | 2004 | 39 | |
| 11 | 2004 | 2 | |
| 12 | 1999 | 31 | |
| 13 | Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer. | 1996 | 21 |
| 14 | 1996 | 16 | |
| 15 | Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. | 1990 | 170 |
| 16 | 1990 | 1 | |
| 17 | 1990 | 21 | |
| 18 | 1986 | 13 | |
| 19 | 1977 | 7 | |
| 20 | 1976 | 116 |
About H.G. Meerpohl
H.G. Meerpohl is a scholar working on Reproductive Medicine, Oncology and Dermatology, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Ovarian cancer diagnosis and treatment (5 papers), HER2/EGFR in Cancer Research (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Chemotherapy-related skin toxicity (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), Intraperitoneal and Appendiceal Malignancies (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Reproductive Medicine (360 citations), Obstetrics and Gynecology (163 citations) and Biophysics (93 citations). H.G. Meerpohl has collaborated with scholars based in Germany, Switzerland and Estonia. Frequent co-authors include Marie‐Luise Lohmann‐Matthes, Herbert Fischer, Andreas du Bois, Jalid Sehouli, H Engler, G. W. Löhr, Wolfram Brugger, Reinhard Andreesen, Stefan W. Krause and Carmen Scheibenbogen. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Immunology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.